CR also improved behavioral and molecular signs in a MPTP-induced mouse model of Parkinson’s Disease (PD) by increasing the levels of the brain derived neurotrophic factor and the glial cell-derived neurotrophic factor [61]. This evidence concerns the gene GDNF and Parkinson disease.